Cited by 90Pomegranate: compositions and health benefitsNatural Antidiabetic Agents StudiesCardiovascular Function and Risk Factors

Punicalagin, an active component in pomegranate, ameliorates cardiac mitochondrial impairment in obese rats via AMPK activation

Open access
Cao, Ke, Xu, Jie, Pu, Wenjun, Dong, Zhizhong, Sun, Lei, Zang, Weijin, Gao, Feng, Zhang, Yong +2 more·2015·Scientific Reports

Abstract

Obesity is associated with an increasing prevalence of cardiovascular diseases and metabolic syndrome. It is of paramount importance to reduce obesity-associated cardiac dysfunction and impaired energy metabolism. In this study, the activation of the AMP-activated protein kinase (AMPK) pathway by punicalagin (PU), a major ellagitannin in pomegranate was investigated in the heart of a rat obesity model. In male SD rats, eight-week administration of 150 mg/kg pomegranate extract (PE) containing 40% punicalagin sufficiently prevented high-fat diet (HFD)-induced obesity associated accumulation of cardiac triglyceride and cholesterol as well as myocardial damage. Concomitantly, the AMPK pathway was activated, which may account for prevention of mitochondrial loss via upregulating mitochondrial biogenesis and amelioration of oxidative stress via enhancing phase II enzymes in the hearts of HFD rats. Together with the normalized expression of uncoupling proteins and mitochondrial dynamic regulators, PE significantly prevented HFD-induced cardiac ATP loss. Through in vitro cultures, we showed that punicalagin was the predominant component that activated AMPK by quickly decreasing the cellular ATP/ADP ratio specifically in cardiomyocytes. Our findings demonstrated that punicalagin, the major active component in PE, could modulate mitochondria and phase II enzymes through AMPK pathway to prevent HFD-induced cardiac metabolic disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep14014

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Punicalagin, by activating AMPK, prevented HFD-related cardiac disorders via modulating mitochondria as well as phase II enzymes.

    “These findings collectively elucidated that punicalagin, by activating AMPK, prevented HFD-related cardiac disorders via modulating mitochondria as well as phase II enzymes [142].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [142]

  • Pomegranate extract activated AMPK, which may be responsible for the intervention of mitochondrial loss through promoting mitochondrial biogenesis and the attenuation of oxidative stress by means of upregulating phase II enzymes in HFD hearts.

    “Concomitantly, pomegranate extract activated AMPK, which may be responsible for the intervention of mitochondrial loss through promoting mitochondrial biogenesis and the attenuation of oxidative stress by means of upregulating phase II enzymes in HFD hearts [142].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [142]

  • Punicalagin protects against HFD-induced cardiac disorders by activating AMPK pathway and promoting mitochondrial biogenesis.

    “Punicalagin, the major active component in pomegranate extract, protects against HFD-induced cardiac disorders by activating AMPK pathway and promoting mitochondrial biogenesis [142].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [142]

  • In Sprague Dawley rats, administration of pomegranate extract, composed of 40% punicalagin, effectively blocked HFD-induced cardiac accumulation of fat and myocardial damage.

    “In Sprague Dawley rats, administration of pomegranate extract, composed of 40% punicalagin, effectively blocked HFD-induced cardiac accumulation of fat (e.g., cholesterol and triglycerides) and myocardial damage [142].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [142]

  • Punicalagin was the main component of pomegranate extract that specifically activated AMPK in cardiomyocytes via quickly reducing the intracellular ATP-to-ADP ratio.

    “Cell culture study demonstrated that punicalagin was the main component of pomegranate extract that specifically activated AMPK in cardiomyocytes via quickly reducing the intracellular ATP-to-ADP ratio [142].”

    From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [142]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cao, K., Xu, J., Pu, W., Dong, Z., Sun, L., Zang, W., Gao, F., Zhang, Y., Feng, Z., & Liu, J.
Affiliations
  • Xi'an Jiaotong University (CN)
  • Nestlé (China) (CN)
  • Air Force Medical University (CN)
  • Tianjin University of Sport (CN)
Corresponding author
  • Feng, Zhihui
  • Liu, Jiankang
Venue
Scientific Reports
Published
2015-09-15
Volume
5
Issue
1
Pages
14014-14014
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2218213969
Cited by
90
References
48
Citations by year
2026: 3 · 2025: 4 · 2024: 7 · 2023: 9 · 2022: 10 · 2021: 16 · 2020: 9 · 2019: 7 · 2018: 5 · 2017: 11 · 2016: 7 · 2015: 1
FWCI
7.70
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (2014CB548200, 10SYSYJC28400, 81201023)
  • National Key Research and Development Program of China (2014CB548200, 2015CB553602)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Pomegranate: compositions and health benefits
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
punicalagin, pomegranate extract, ellagitannins, obesity, high-fat diet, cardiac mitochondrial dysfunction, AMPK activation, mitochondrial biogenesis, oxidative stress, phase II enzymes, uncoupling proteins, mitochondrial dynamics, cardiomyocytes, myocardial energy metabolism, triglyceride accumulation, cholesterol accumulation
MeSH terms
Animals, Organelle Biogenesis, Mitochondria, Heart, Myocardium, Obesity, Phosphorylation, Signal Transduction, Oxidative Stress, Lythraceae, Myocytes, Cardiac, Hydrolyzable Tannins, Rats, AMP-Activated Protein Kinases, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review